Skip to main content
. 2022 Mar 21;33(4):e50. doi: 10.3802/jgo.2022.33.e50

Table 2. Characteristics of patients with and without p53 signatures.

Characteristics RRSO patients (n=13) Control patients (n=17)
p53 signature (n=7) No p53 signature (n=6) p-value p53 signature (n=6) No p53 signature (n=11) p-value
Mean age at operation (yr) 49.4 47.3 0.57* 49 44.9 0.11*
BMI (mean) 20.95 21.03 0.95* 22.97 21.83 0.48*
Parity 0.9* 0.9
Nulliparous 1 1 4 7
Parous 6 5 2 4
Hormone therapy for breast cancer 0.85
No 5 4
Yes 2 2
GnRH analog 0.11
No 2 8
Yes 4 3
OC use - -
Never 7 6 6 11
Ever 0 0 0 0
Race - -
Asian 7 6 6 11
BRCA1/2 pathogenic variant 0.053 NA
BRCA1 6 2
BRCA2 1 4

NA, not available.

*t-test; χ2 test.